Global Blood Therapeutics, Inc. GBT
68.49 +68.49
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2021 · select a line to chart its full history
Income statement
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 194.75M | 123.80M | 2.11M | 0 | 0 | |
| 191.43M | 121.82M | 2.06M | 0 | 0 | |
| -287.69M | -244.16M | -289.58M | -182.74M | -119.25M | |
| -303.09M | -247.55M | -266.77M | -174.19M | -117.02M | |
| -4.81 | -4.04 | -4.57 | -3.41 | -2.76 |
Balance sheet
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| 687.15M | 497.20M | 304.63M | 277.75M | 199.38M | |
| 939.21M | 724.00M | 796.10M | 617.64M | 356.72M | |
| 742.80M | 307.85M | 217.41M | 44.84M | 37.92M | |
| 653.95M | 227.99M | 145.92M | 0 | 0 | |
| 196.41M | 416.16M | 578.69M | 572.80M | 318.80M |
Cash flow
| Fiscal year | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 | FY 2017 Dec 31, 2017 |
|---|---|---|---|---|---|
| -256.81M | -211.86M | -194.42M | -135.38M | -93.02M | |
| 12.11M | 317.31M | -76.86M | -184.16M | -35.00M | |
| 434.33M | 87.12M | 298.16M | 397.91M | 235.19M | |
| -3.23M | -8.75M | -3.42M | -4.75M | -3.10M | |
| 189.95M | 192.57M | 26.88M | 78.37M | 107.17M |